Diffusion tensor MRI contributes to differentiate Richardson's syndrome from PSP-parkinsonism

Neurobiology of Aging

Volumn 33, Issue 12, 2012, Pages 2817-2826

  Agosta, Federica ^a   Pievani, Michela ^a   Svetel, Marina ^b   Ječmenica Lukić, Milica ^b   Copetti, Massimiliano ^c   Tomić, Aleksandra ^b   Scarale, Antonio ^a   Longoni, Giulia ^a,d   Comi, Giancarlo ^d   Kostić, Vladimir S ^b   Filippi, Massimo ^a,d  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Atrophy; Diffusion tensor MRI; PSP Parkinsonism; Richardson's syndrome

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN RADIOGRAPHY; BRAIN REGION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS CALLOSUM; DIAGNOSTIC ACCURACY; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; IN VIVO STUDY; MALE; MIDDLE CEREBELLAR PEDUNCLE; MINI MENTAL STATE EXAMINATION; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SUPERIOR CEREBELLAR PEDUNCLE; UNIFIED PARKINSON DISEASE RATING SCALE; VOLUMETRY; WHITE MATTER INJURY;

AGED; AGED, 80 AND OVER; ATROPHY; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOENCEPHALOPATHIES; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84866751693     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.02.002     Document Type: Article

References (46)

1. Agosta F., Kostić V.S., Galantucci S., Mesaros S., Svetel M., Pagani E., Stefanova E., Filippi M. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study. Eur. J. Neurosci 2010, 32:640-647.
2. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007, 38:95-113.
3. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851.
4. Basser P.J., Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson. B 1996, 111:209-219.
5. Boeve B.F., Lang A.E., Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann. Neurol 2003, 54(Suppl 5):S15-S19.
6. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997, 49:1284-1288.
7. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999, 52:1214-1220.
8. Canu E., Agosta F., Baglio F., Galantucci S., Nemni R., Filippi M. Diffusion tensor magnetic resonance imaging tractography in progressive supranuclear palsy. Mov. Disord 2011, 26:1752-1755.
9. Cordato N.J., Duggins A.J., Halliday G.M., Morris J.G., Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005, 128:1259-1266.
10. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
11. Fahn S., Elton R.L. Unified Parkinson's Disease Rating Scale. Recent Developments in Parkinson's Disease II 1987, 153-163. Members of the UPDRS Development Committee, Macmillan, New York. S. Fahn, M. C, M. Goldstein, D.B. Calne (Eds.).
12. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol. 1987, 149:351-356.
13. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198.
14. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1988, 51:745-752.
15. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., Kaufmann H., Klockgether T., Lang A.E., Lantos P.L., Litvan I., Mathias C.J., Oliver E., Robertson D., Schatz I., Wenning G.K. Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci 1999, 163:94-98.
16. Hamilton M. The assessment of anxiety states by rating. Br. J Med Psychol 1959, 32:50-55.
17. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
18. Hauw J.J., Daniel S.E., Dickson D., Horoupian D.S., Jellinger K., Lantos P.L., McKee A., Tabaton M., Litvan I. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994, 44:2015-2019.
19. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
20. Hosmer D.W., Lemeshow S. Applied Logistic Regression 2000, Wiley, New York.
21. Ishizawa K., Lin W.L., Tiseo P., Honer W.G., Davies P., Dickson D.W. A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol 2000, 59:513-524.
22. Jellinger K.A. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener. Dis 2008, 5:339-346.
23. Josephs K.A., Whitwell J.L., Eggers S.D., Senjem M.L., Jack C.R. Gray matter correlates of behavioral severity in progressive supranuclear palsy. Mov. Disord 2011, 26:493-498.
24. Knake S., Belke M., Menzler K., Pilatus U., Eggert K.M., Oertel W.H., Stamelou M., Höglinger G.U. In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov. Disord. 2010, 25:1232-1238.
25. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., Goetz C.G., Golbe L.I., Grafman J., Growdon J.H., Hallett M., Jankovic J., Quinn N.P., Tolosa E., Zee D.S. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9.
26. Litvan I., Bhatia K.P., Burn D.J., Goetz C.G., Lang A.E., McKeith I., Quinn N., Sethi K.D., Shults C., Wenning G.K. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov. Disord 2003, 18:467-486. Movement Disorders Society Scientific Issues Committee.
27. Longoni G., Agosta F., Kostić V.S., Stojković T., Pagani E., Stošić-Opinćal T., Filippi M. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Mov. Disord. 2011, 26:247-255.
28. Marin R.S., Biedrzycki R.C., Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991, 38:143-162.
29. Morris H.R., Gibb G., Katzenschlager R., Wood N.W., Hanger D.P., Strand C., Lashley T., Daniel S.E., Lees A.J., Anderton B.H., Revesz T. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 2002, 125:969-975.
30. Nath U., Ben-Shlomo Y., Thomson R.G., Morris H.R., Wood N.W., Lees A.J., Burn D.J. The prevalence of progressive supranuclear palsy, (Richardson, Steele-Olszewski syndrome) in the UK. Brain 2001, 124:1138-1449.
31. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp 2002, 15:1-25.
32. Nilsson C., Markenroth Bloch K., Brockstedt S., Lätt J., Widner H., Larsson E.M. Tracking the neurodegeneration of parkinsonian disorders-a pilot study. Neuroradiology 2007, 49:111-119.
33. Padovani A., Borroni B., Brambati S.M., Agosti C., Broli M., Alonso R., Scifo P., Bellelli G., Alberici A., Gasparotti R., Perani D. Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 2006, 77:457-463.
34. Paviour D.C., Price S.L., Stevens J.M., Lees A.J., Fox N.C. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005, 64:675-679.
35. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med 2008, 27:157-172. Discussion, 207-212.
36. Quattrone A., Nicoletti G., Messina D., Fera F., Condino F., Pugliese P., Lanza P., Barone P., Morgante L., Zappia M., Aguglia U., Gallo O. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008, 246:214-221.
37. Schofield E.C., Hodges J.R., Macdonald V., Cordato N.J., Kril J.J., Halliday G.M. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. Mov. Disord 2011, 26:256-263.
38. Schrag A., Ben-Shlomo Y., Quinn N.P. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999, 354:1771-1775.
39. Seppi K., Poewe W. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin. N. Am 2010, 20:29-55.
40. Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009, 44:83-98.
41. Wang J., Wai Y., Lin W.Y., Ng S., Wang C.H., Hsieh R., Hsieh C., Chen R.S., Lu C.S. Microstructural changes in patients with progressive supranuclear palsy: a diffusion tensor imaging study. J. Magn. Reson. Imaging 2011, 32:69-75.
42. Whitwell J.L., Master A.V., Avula R., Kantarci K., Eggers S.D., Edmonson H.A., Jack C.R., Josephs K.A. Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch. Neurol 2011, 68:753-760.
43. Williams D.R., de Silva R., Paviour D.C., Pittman A., Watt H.C., Kilford L., Holton J.L., Revesz T., Lees A.J. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005, 128:1247-1258.
44. Williams D.R., Holton J.L., Strand C., Pittman A., de Silva R., Lees A.J., Revesz T. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 2007, 130:1566-1576.
45. Williams D.R., Holton J.L., Strand K., Revesz T., Lees A.J. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov. Disord 2007, 22:2235-2241.
46. Williams D.R., Lees A.J. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?. Mov. Disord 2010, 25:357-362.